Clinical Trial

Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

Completed
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
Protocol Amendment History 4 changes
critical Trial completed 2026-08-07
notable Enrollment reduced: 34 -> 29 participants 2026-08-07
notable Primary completion moved earlier: 2026-06 -> 2026-04-05 2026-08-07
minor Completion moved earlier: 2026-06 -> 2026-04-05 2026-08-07
Trial Details
NCT Number NCT07428889
Lead Sponsor Shaklee Corporation
Collaborators: Biofortis Clinical Research, Inc., Nlumn LLC
Conditions Healthy Adult
Enrollment 29 participants
Start Date 2026-02-17
Primary Completion 2026-04-05 (estimated)
Study Completion 2026-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-06